How do I install the Endo T Ongoing Monitoring 6mo skill?

Run npx skillmds@latest add dromlakhani/endo-t-ongoing-monitoring-6mo in your terminal (requires Node.js), paste this page's agent-chat prompt into Claude, Cursor, or any MCP-connected agent, or download the SKILL.md file and copy it into your agent's skills directory.

Is Endo T Ongoing Monitoring 6mo safe to use?

This skill has not completed SkillMD's automated safety review yet. Independent scanners report: SkillSpector: PASS, Skill Scanner: PASS. Capability flags: docs only. SkillMD never runs a skill's scripts for you; review the SKILL.md before installing.

Which AI agents work with Endo T Ongoing Monitoring 6mo?

This skill is tagged as working with Claude Code, Claude.ai, OpenAI Codex. SKILL.md is an open format, so most agents that read a skills directory can load it too.

Is Endo T Ongoing Monitoring 6mo free to use?

Yes. Installing skills from SkillMD is free, and the skill stays under its author's original license.

Who published Endo T Ongoing Monitoring 6mo?

dromlakhani (@dromlakhani) published this skill. Their other Agent Skills are listed on their SkillMD profile.

Endo T Ongoing Monitoring 6mo by dromlakhani

Name: Endo T Ongoing Monitoring 6mo
Rating: 4.2 (5 reviews)
Author: dromlakhani

Endo T Ongoing Monitoring 6mo

Recommends reviewing serum testosterone levels every 6 months during ongoing therapy to monitor for excessive use and signs of androgen excess such as hirsutism or acne. It is indicated when a clinician manages a woman receiving long-term testosterone therapy and needs to evaluate for adverse effects or consider dose adjustment.

dromlakhani Updated Sep 8, 2026 10 repo stars

File contents

Suggest routine testosterone monitoring every 6 months during ongoing therapy

STEP 1 — Gather Information

Collect current testosterone therapy details (dose, formulation, duration), baseline testosterone level if available, and assess for symptoms of androgen excess (hirsutism, acne, voice changes, clitoromegaly) and any adverse effects.

STEP 2 — Rule In / Rule Out

Is the patient receiving ongoing testosterone therapy? If yes, proceed to Step 3; if no, monitoring per this guideline is not required.

STEP 3 — Classify or Stratify

Evaluate testosterone level and symptoms: Is the level within the target premenopausal range and are there no signs of androgen excess? If yes, classify as “adequate”; if level is elevated or symptoms of excess are present, classify as “excess”.

STEP 4 — Decide

If classified as “adequate”, continue current therapy and schedule next testosterone check in 6 months. If classified as “excess”, reduce dose, discontinue therapy, or investigate further before adjusting treatment.

Clinical Guardrails / Mimics / Pitfalls

Do not rely solely on symptoms; always pair with serum testosterone measurement. Avoid using testosterone levels to diagnose androgen deficiency in healthy women. Do not prescribe oral testosterone formulations due to safety concerns. Monitor for virilizing signs even if levels appear normal, as tissue sensitivity varies. Do not exceed physiological dosing regimens without specialist guidance.

Concrete Clinical Example

A 52-year-old woman on transdermal testosterone 300 µg/day for HSDD reports no new hair growth or acne at her routine visit. Her serum testosterone is 38 ng/dL (within premenopausal range). Decision: Continue current dose and repeat testosterone measurement in 6 months.

Source: Androgen Therapy in Women: A Reappraisal: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2014, DOI:10.1210/jc.2014-2260

---name: endo-t-ongoing-monitoring-6modescription: Recommends reviewing serum testosterone levels every 6 months during ongoing therapy to monitor for excessive use and signs of androgen excess such as hirsutism or acne. It is indicated when a clinician manages a woman receiving long-term testosterone therapy and needs to evaluate for adverse effects or consider dose adjustment.---# Suggest routine testosterone monitoring every 6 months during ongoing therapy## STEP 1 — Gather InformationCollect current testosterone therapy details (dose, formulation, duration), baseline testosterone level if available, and assess for symptoms of androgen excess (hirsutism, acne, voice changes, clitoromegaly) and any adverse effects.## STEP 2 — Rule In / Rule OutIs the patient receiving ongoing testosterone therapy? If yes, proceed to Step 3; if no, monitoring per this guideline is not required.## STEP 3 — Classify or StratifyEvaluate testosterone level and symptoms: Is the level within the target premenopausal range and are there no signs of androgen excess? If yes, classify as “adequate”; if level is elevated or symptoms of excess are present, classify as “excess”.## STEP 4 — DecideIf classified as “adequate”, continue current therapy and schedule next testosterone check in 6 months. If classified as “excess”, reduce dose, discontinue therapy, or investigate further before adjusting treatment.## Clinical Guardrails / Mimics / PitfallsDo not rely solely on symptoms; always pair with serum testosterone measurement. Avoid using testosterone levels to diagnose androgen deficiency in healthy women. Do not prescribe oral testosterone formulations due to safety concerns. Monitor for virilizing signs even if levels appear normal, as tissue sensitivity varies. Do not exceed physiological dosing regimens without specialist guidance.## Concrete Clinical ExampleA 52-year-old woman on transdermal testosterone 300 µg/day for HSDD reports no new hair growth or acne at her routine visit. Her serum testosterone is 38 ng/dL (within premenopausal range). Decision: Continue current dose and repeat testosterone measurement in 6 months.**Source:** Androgen Therapy in Women: A Reappraisal: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2014, DOI:10.1210/jc.2014-2260

Frequently asked questions